This is a delivery order contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Mcbee Moore & Vanik IP, LLC, a boutique intellectual property law firm. The contract, with an award value of $12,220.50, requires the vendor to file a national stage patent application in Japan to secure patent protection for an invention described in a patent application identified as E-118-2022-0-JP-01.
The contract is issued under the NIH Patent Legal Services master Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle, which has a total ceiling value of $386 million and focuses on biotechnology-related patent services. Mcbee Moore & Vanik IP, LLC also holds a second $115 million IDIQ contract with NIH for chemistry-related patent services. These contracts allow various NIH institutes and centers, as well as the Centers for Disease Control and Prevention, to issue task orders for a wide range of patent prosecution and intellectual property support services.
The contract does not have a set-aside designation and is set to be completed by January 28, 2025.
Generated 11/1/24, 9:02 AM